We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Unlocking Q1 Potential of Teladoc (TDOC): Exploring Wall Street Estimates for Key Metrics
Read MoreHide Full Article
Analysts on Wall Street project that Teladoc (TDOC - Free Report) will announce quarterly loss of -$0.32 per share in its forthcoming report, representing a decline of 68.4% year over year. Revenues are projected to reach $612.3 million, declining 2.7% from the same quarter last year.
The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
In light of this perspective, let's dive into the average estimates of certain Teladoc metrics that are commonly tracked and forecasted by Wall Street analysts.
Analysts forecast 'Revenues by Segment- BetterHelp' to reach $217.49 million. The estimate indicates a year-over-year change of -9.3%.
Analysts expect 'Revenues by Segment- Integrated Care' to come in at $391.80 million. The estimate points to a change of +0.6% from the year-ago quarter.
Analysts predict that the 'Revenues by Segment- BetterHelp- Therapy Services' will reach $215.64 million. The estimate indicates a year-over-year change of -8%.
The consensus estimate for 'Revenues by Segment- BetterHelp- Other Wellness Services' stands at $4.21 million. The estimate suggests a change of -22.9% year over year.
The average prediction of analysts places 'Revenue by Type- Access fees' at $506.54 million. The estimate indicates a year-over-year change of -3.7%.
Analysts' assessment points toward 'Revenue by Type- Other' reaching $106.74 million. The estimate suggests a change of +3% year over year.
It is projected by analysts that the 'U.S. Integrated Care Members' will reach 99.14 million. The estimate is in contrast to the year-ago figure of 102.50 million.
Based on the collective assessment of analysts, 'Adjusted EBITDA- BetterHelp' should arrive at $2.88 million. Compared to the present estimate, the company reported $7.71 million in the same quarter last year.
The collective assessment of analysts points to an estimated 'Adjusted EBITDA- Integrated Care' of $52.28 million. The estimate is in contrast to the year-ago figure of $50.38 million.
Shares of Teladoc have demonstrated returns of +13.8% over the past month compared to the Zacks S&P 500 composite's +12.8% change. With a Zacks Rank #3 (Hold), TDOC is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
Unlocking Q1 Potential of Teladoc (TDOC): Exploring Wall Street Estimates for Key Metrics
Analysts on Wall Street project that Teladoc (TDOC - Free Report) will announce quarterly loss of -$0.32 per share in its forthcoming report, representing a decline of 68.4% year over year. Revenues are projected to reach $612.3 million, declining 2.7% from the same quarter last year.
The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Before a company announces its earnings, it is essential to take into account any changes made to earnings estimates. This is a valuable factor in predicting the potential reactions of investors toward the stock. Empirical research has consistently shown a strong correlation between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
In light of this perspective, let's dive into the average estimates of certain Teladoc metrics that are commonly tracked and forecasted by Wall Street analysts.
Analysts forecast 'Revenues by Segment- BetterHelp' to reach $217.49 million. The estimate indicates a year-over-year change of -9.3%.
Analysts expect 'Revenues by Segment- Integrated Care' to come in at $391.80 million. The estimate points to a change of +0.6% from the year-ago quarter.
Analysts predict that the 'Revenues by Segment- BetterHelp- Therapy Services' will reach $215.64 million. The estimate indicates a year-over-year change of -8%.
The consensus estimate for 'Revenues by Segment- BetterHelp- Other Wellness Services' stands at $4.21 million. The estimate suggests a change of -22.9% year over year.
The average prediction of analysts places 'Revenue by Type- Access fees' at $506.54 million. The estimate indicates a year-over-year change of -3.7%.
Analysts' assessment points toward 'Revenue by Type- Other' reaching $106.74 million. The estimate suggests a change of +3% year over year.
It is projected by analysts that the 'U.S. Integrated Care Members' will reach 99.14 million. The estimate is in contrast to the year-ago figure of 102.50 million.
Based on the collective assessment of analysts, 'Adjusted EBITDA- BetterHelp' should arrive at $2.88 million. Compared to the present estimate, the company reported $7.71 million in the same quarter last year.
The collective assessment of analysts points to an estimated 'Adjusted EBITDA- Integrated Care' of $52.28 million. The estimate is in contrast to the year-ago figure of $50.38 million.
View all Key Company Metrics for Teladoc here>>>Shares of Teladoc have demonstrated returns of +13.8% over the past month compared to the Zacks S&P 500 composite's +12.8% change. With a Zacks Rank #3 (Hold), TDOC is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .